1. Home
  2. ELUT vs IRIX Comparison

ELUT vs IRIX Comparison

Compare ELUT & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.70

Market Cap

25.2M

Sector

Health Care

ML Signal

HOLD

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.96

Market Cap

20.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELUT
IRIX
Founded
2015
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.2M
20.2M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ELUT
IRIX
Price
$0.70
$0.96
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
242.1K
72.0K
Earning Date
11-06-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,746,000.00
$50,647,000.00
Revenue This Year
N/A
$9.61
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
4.58
52 Week Low
$0.58
$0.78
52 Week High
$4.84
$1.89

Technical Indicators

Market Signals
Indicator
ELUT
IRIX
Relative Strength Index (RSI) 44.43 50.09
Support Level $0.66 $0.91
Resistance Level $0.72 $0.96
Average True Range (ATR) 0.06 0.04
MACD 0.02 0.01
Stochastic Oscillator 52.63 87.73

Price Performance

Historical Comparison
ELUT
IRIX

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: